MENU

OTLK Outlook Therapeutics Forecast, Technical & Fundamental Analysis

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications... Show more

Industry: #Biotechnology
OTLK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
OTLK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of biosimilar versions of biopharmaceuticals

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
111 S. Wood Avenue
Phone
+1 609 619-3990
Employees
17
Web
https://www.outlooktherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRCEX12.84N/A
N/A
Meridian Hedged Equity C
IACIX11.83N/A
N/A
VY® American Century Sm-Mid Cp Val I
ODVIX41.26N/A
N/A
Invesco Developing Markets R6
AUIZX40.12N/A
N/A
AB Equity Income Z
FAPCX18.89N/A
N/A
Fidelity Intl Cptl Apprec K6

OTLK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OTLK has been loosely correlated with APVO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if OTLK jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
-0.18%
APVO - OTLK
45%
Loosely correlated
+0.55%
ICU - OTLK
36%
Loosely correlated
-3.51%
GNPX - OTLK
34%
Loosely correlated
N/A
CYTK - OTLK
33%
Loosely correlated
+0.20%
PDSB - OTLK
33%
Loosely correlated
-6.47%
More
Outlook Therapeutics (OTLK) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com